Management of Upper Gastrointestinal Bleeding
The management of upper gastrointestinal (GI) bleeding requires immediate fluid resuscitation with crystalloids, risk stratification using the Glasgow-Blatchford score, administration of high-dose IV proton pump inhibitors, and endoscopy within 24 hours of presentation after initial stabilization. 1
Initial Assessment and Resuscitation
Hemodynamic Stabilization
- Initiate fluid resuscitation with crystalloids (Ringer's lactate) for hemodynamically unstable patients 1
- Place two large-bore IV cannulae and insert urinary catheter to monitor output in severe cases 1
- Monitor vital signs hourly (pulse, blood pressure) 1
- Transfuse red blood cells when hemoglobin is <100 g/L or with active bleeding with shock 1
- Aim for a hemoglobin threshold of 70-80 g/L for transfusion in most patients 2, 3
Risk Stratification
Medical Therapy
Proton Pump Inhibitor (PPI) Therapy
- Start high-dose IV PPI therapy (80 mg IV bolus followed by 8 mg/hour continuous infusion) immediately 1
- Continue high-dose IV PPI for 72 hours after successful endoscopic hemostasis 1
- Transition to oral PPI 40 mg twice daily for 11 days after IV therapy 1
- Continue once-daily oral PPI to complete a total of 6-8 weeks for complete mucosal healing 1
Additional Pharmacotherapy
Endoscopic Management
Timing of Endoscopy
Endoscopic Therapy Based on Etiology
- For peptic ulcers with high-risk stigmata (active bleeding or visible vessel):
- For variceal bleeding:
Post-Endoscopy Care
Continued Medical Therapy
Management of Recurrent Bleeding
Antithrombotic Therapy Management
- Restart low-dose aspirin therapy as soon as cardiovascular risks outweigh gastrointestinal risks, usually within 7 days 1
- Consider PPI therapy for patients receiving single or dual antiplatelet therapy to prevent recurrent bleeding 1
- Early reintroduction of antithrombotic agents appears to improve outcomes 1, 2
Special Considerations
For NSAID-related gastritis:
For patients with liver disease:
Lifestyle modifications for gastritis:
Common Pitfalls to Avoid
- Delaying endoscopy beyond 24 hours in high-risk patients 1
- Using epinephrine injection alone for endoscopic hemostasis 1
- Failing to administer high-dose PPI therapy 1
- Neglecting H. pylori testing in patients with peptic ulcers 1
- Premature discontinuation of PPI therapy 1
- Prolonged withholding of antiplatelet therapy in patients with cardiovascular indications 1
- Inadequate resuscitation before endoscopy 6
- Failure to correct coagulopathy early 6